- Home
- CNTX vs FNGR Comparison
CNTX vs FNGR Comparison
Compare CNTX & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- FNGR
- Stock Information
- Founded
- CNTX 2015
- FNGR 2016
- Country
- CNTX United States
- FNGR Singapore
- Employees
- CNTX N/A
- FNGR N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- FNGR Computer Software: Prepackaged Software
- Sector
- CNTX Health Care
- FNGR Technology
- Exchange
- CNTX Nasdaq
- FNGR Nasdaq
- Market Cap
- CNTX 78.0M
- FNGR 87.9M
- IPO Year
- CNTX 2021
- FNGR N/A
- Fundamental
- Price
- CNTX $0.79
- FNGR $1.42
- Analyst Decision
- CNTX Strong Buy
- FNGR
- Analyst Count
- CNTX 5
- FNGR 0
- Target Price
- CNTX $5.25
- FNGR N/A
- AVG Volume (30 Days)
- CNTX 145.6K
- FNGR 486.0K
- Earning Date
- CNTX 08-06-2025
- FNGR 07-15-2025
- Dividend Yield
- CNTX N/A
- FNGR N/A
- EPS Growth
- CNTX N/A
- FNGR N/A
- EPS
- CNTX N/A
- FNGR N/A
- Revenue
- CNTX N/A
- FNGR $35,692,374.00
- Revenue This Year
- CNTX N/A
- FNGR N/A
- Revenue Next Year
- CNTX N/A
- FNGR N/A
- P/E Ratio
- CNTX N/A
- FNGR N/A
- Revenue Growth
- CNTX N/A
- FNGR 11.55
- 52 Week Low
- CNTX $0.49
- FNGR $1.03
- 52 Week High
- CNTX $2.70
- FNGR $5.20
- Technical
- Relative Strength Index (RSI)
- CNTX 58.08
- FNGR 37.22
- Support Level
- CNTX $0.68
- FNGR $1.43
- Resistance Level
- CNTX $0.73
- FNGR $1.50
- Average True Range (ATR)
- CNTX 0.05
- FNGR 0.10
- MACD
- CNTX -0.00
- FNGR 0.01
- Stochastic Oscillator
- CNTX 55.65
- FNGR 8.92
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.